NEW ORLEANS — A glycoprotein IIb/IIIa inhibitor (GPI) that can be administered subcutaneously before a person having an ST-elevated myocardial infarction (STEMI) arrives at the hospital improved key ...

Hospitals that apply a comprehensive protocol when providing STEMI care stand to improve key process metrics for patients irrespective of their race, data from the Cleveland Clinic suggest. In the ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...